GreenCare Pharma
Vinhedo, São Paulo, 13288006, Brazil
Location status: Recruiting
Location contact
Fernando Pacheco, MD
PRINCIPAL_INVESTIGATOR
Study coordinator, MsC PhD
CONTACT
NCT Number: NCT06807762
The goal of this Phase I clinical trial is to assess the pharmacokinetic availability and safety and tolerability profile of Extrato de Cannabis sativa GreenCare 79.14 mg/mL. The main question it aims to answer is:
• Is the Extrato de Cannabis sativa GreenCare 79,14 mg/mL safe?
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Phase 1
Vinhedo, São Paulo, 13288006, Brazil
Location status: Recruiting
Fernando Pacheco, MD
PRINCIPAL_INVESTIGATOR
Study coordinator, MsC PhD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Having participated in any experimental study or ingested any experimental drug within 1 (one) year prior to the start of this study;
Healthy subjects will be treated with a solution of Cannabis sativa extract diluted in MCT oil, at doses ranging from 39.62 mg to 791.4 mg. This protocol will be divided into two stages:
Stage 1 - Determination of the Maximum Tolerated Dose (MTD): Participants (n=60) will be dynamically randomized and will receive Cannabis sativa extract (GreenCare, 79.14 mg/mL) as a single dose after breakfast, with doses ranging from 39.62 mg to 791.4 mg.
Stage 2 - Assessment of the MTD: All participants (n=12) will receive the MTD determined in Stage 1, administered in two daily doses for 14 consecutive days.
Other names: Extrato de Cannabis sativa GreenCare 79.14 mg/mL
Time frame: Up to 5 days
Time frame: Up to 5 days
Time frame: Up to 5 days
Contact information is provided by the study sponsor or research team.
Fabio Furtado
CONTACT
Helena Joaquim, MsC, PhD
CONTACT
GreenCare Pharma
Industry
Phase I Clinical Trial to Assess Tolerability, Safety, and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare 79.14 mg/mL - Drops Solution - in Healthy Research Participants of Both Sexes in a Fed State
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07669077
Healthy
Salt Lake City, Utah, United States
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07739238
Healthy
Balıkesir, In the USA Or Canada, Please Select..., Turkey (Türkiye)
View Trial Details